Literature DB >> 22464450

A novel function of IL-2: chemokine/chemoattractant/retention receptor genes induction in Th subsets for skin and lung inflammation.

Rahul Sharma1, Sun-Sang J Sung, Felicia Gaskin, Shu Man Fu, Shyr-Te Ju.   

Abstract

The Foxp3(+)CD4(+) regulatory T-cell (Treg)-deficient Scurfy (Sf) mice rapidly develop severe inflammation in the skin and lungs with expanded Th subsets bearing increased expression of various chemokine/chemoattractant/retention receptor genes (CRG). Nine different double mutants were generated to elucidate their roles in the skin and lung inflammation. The expanded Th2 response and the increased expression of several CRG for the skin and lung inflammation were inhibited in Sf.Il2(-/-) mice as previously described using microarray analysis. Herein in a reciprocal approach, we demonstrated that Sf.Il4(-/-) and Sf.Stat6(-/-) mice, despite lacking Th2 cytokines IL-4, IL-5, and IL-13, as well as the IL-4/STAT6-dependent CRG expression, the inflammation in the skin and lungs remained. The effect of the other Th1 cytokine IFN-γ was studied in Sf.Ifng(-/-) mice in which the multi-organ inflammation (MOI) was delayed but fully developed afterward with enhanced CRG expression except for the IFN-γ-dependent Cxcr3 in CD4(+) T-cells. Similarly, a transient delay of MOI was observed for Sf.Itgae(-/-) mice but their Th subsets and the critical CRG expansion remained. Ltb4r1(-/-), Alox5(-/-), Cx3cr1(gfp/gfp), or Il10(-/-) mutant genes also failed to effectively block inflammation in the skin and lungs in Sf mice. Our study has identified a novel function of IL-2 as a powerful Th1 cytokine that induces a panel of CRG in Th subsets required for skin and lung inflammation in Sf mice. The CRG panel induced by IL-2 but not by IL-4 or IFN-γ explains the apparent "organ-specific" display of the skin and lung inflammation in Sf mice.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22464450      PMCID: PMC3358580          DOI: 10.1016/j.jaut.2012.02.001

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  28 in total

1.  A new mathematical model for relative quantification in real-time RT-PCR.

Authors:  M W Pfaffl
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

2.  Generation, persistence, and modulation of Th0 effector cells: role of autocrine IL-4 and IFN-gamma.

Authors:  K T Miner; M Croft
Journal:  J Immunol       Date:  1998-06-01       Impact factor: 5.422

3.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse.

Authors:  M E Brunkow; E W Jeffery; K A Hjerrild; B Paeper; L B Clark; S A Yasayko; J E Wilkinson; D Galas; S F Ziegler; F Ramsdell
Journal:  Nat Genet       Date:  2001-01       Impact factor: 38.330

4.  Cooperation between Th1 and Th2 cells in a murine model of eosinophilic airway inflammation.

Authors:  D A Randolph; R Stephens; C J Carruthers; D D Chaplin
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

5.  Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells.

Authors:  F Mach; A Sauty; A S Iarossi; G K Sukhova; K Neote; P Libby; A D Luster
Journal:  J Clin Invest       Date:  1999-10       Impact factor: 14.808

6.  Chemokine receptor expression on MBP-reactive T cells: CXCR6 is a marker of IFNgamma-producing effector cells.

Authors:  Peter A Calabresi; Sung Hae Yun; Rameeza Allie; Katharine A Whartenby
Journal:  J Neuroimmunol       Date:  2002-06       Impact factor: 3.478

7.  Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion.

Authors:  T Imai; K Hieshima; C Haskell; M Baba; M Nagira; M Nishimura; M Kakizaki; S Takagi; H Nomiyama; T J Schall; O Yoshie
Journal:  Cell       Date:  1997-11-14       Impact factor: 41.582

8.  Interleukin-4 receptor alpha chain and STAT6 signaling inhibit gamma interferon but not Th2 cytokine expression within schistosome granulomas.

Authors:  Ahmed Metwali; Arthur Blum; David E Elliott; Joel V Weinstock
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

9.  Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation.

Authors:  G Hansen; G Berry; R H DeKruyff; D T Umetsu
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

10.  Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3.

Authors:  K E Cole; C A Strick; T J Paradis; K T Ogborne; M Loetscher; R P Gladue; W Lin; J G Boyd; B Moser; D E Wood; B G Sahagan; K Neote
Journal:  J Exp Med       Date:  1998-06-15       Impact factor: 14.307

View more
  11 in total

1.  Systemic Activation of NRF2 Alleviates Lethal Autoimmune Inflammation in Scurfy Mice.

Authors:  Takuma Suzuki; Shohei Murakami; Shyam S Biswal; Shimon Sakaguchi; Hideo Harigae; Masayuki Yamamoto; Hozumi Motohashi
Journal:  Mol Cell Biol       Date:  2017-07-14       Impact factor: 4.272

Review 2.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

Review 3.  Regulatory T cells in acute and chronic kidney diseases.

Authors:  Rahul Sharma; Gilbert R Kinsey
Journal:  Am J Physiol Renal Physiol       Date:  2017-09-06

Review 4.  Evaluation and treatment of critical asthma syndrome in children.

Authors:  Alexander Wade; Christopher Chang
Journal:  Clin Rev Allergy Immunol       Date:  2015-02       Impact factor: 8.667

5.  Hookworm-related cutaneous larva migrans in patients living in an endemic community in Brazil: immunological patterns before and after ivermectin treatmen.

Authors:  R Shimogawara; N Hata; A Schuster; H Lesshafft; S Guedes de Oliveira; R Ignatius; N Akao; N Ohta; H Feldmeier
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2013-11-21

Review 6.  IL-2 controls trafficking receptor gene expression and Th2 response for skin and lung inflammation.

Authors:  Shyr-Te Ju; Rahul Sharma; Felicia Gaskin; Shu Man Fu
Journal:  Clin Immunol       Date:  2012-08-04       Impact factor: 3.969

Review 7.  Less travelled roads in clinical immunology and allergy: drug reactions and the environmental influence.

Authors:  Carlo Selmi; Chiara Crotti; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2013-08       Impact factor: 8.667

8.  PARP inhibition by olaparib or gene knockout blocks asthma-like manifestation in mice by modulating CD4(+) T cell function.

Authors:  Mohamed A Ghonim; Kusma Pyakurel; Salome V Ibba; Amir A Al-Khami; Jeffrey Wang; Paulo Rodriguez; Hamada F Rady; Ali H El-Bahrawy; Matthew R Lammi; Moselhy S Mansy; Kamel Al-Ghareeb; Alistair Ramsay; Augusto Ochoa; Amarjit S Naura; A Hamid Boulares
Journal:  J Transl Med       Date:  2015-07-14       Impact factor: 5.531

9.  Aberrant muscle antigen exposure in mice is sufficient to cause myositis in a Treg cell-deficient milieu.

Authors:  Nicholas A Young; Rahul Sharma; Alexandra K Friedman; Benjamin H Kaffenberger; Brad Bolon; Wael N Jarjour
Journal:  Arthritis Rheum       Date:  2013-12

10.  The Biology of Autoimmune Response in the Scurfy Mice that Lack the CD4+Foxp3+ Regulatory T-Cells.

Authors:  Shyr-Te Ju; Rahul Sharma; Felicia Gaskin; John T Kung; Shu Man Fu
Journal:  Biology (Basel)       Date:  2012-04-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.